drugset / Trial / NCT02217683

Use of Inhaled Nitric Oxide to Prevent Pulmonary Hypertension Associated to Stored Blood Transfusion

NCT02217683

Phase 2 Withdrawn Massachusetts General Hospital
RandomizedParallel-groupTriple-blindTreatment

Summary

The objective of this study is to assess if prolonged storage time of a packed red blood cell unit may cause pulmonary vasoconstriction after transfusion, in a susceptible population such as cardiac surgery patients. The investigators will also evaluate the potential reversal effect of Inhaled Nitric Oxide on pulmonary vasoconstriction induced by stored blood transfusions.

Timeline

Start
2016-03
Primary completion
2016-12
Completion
2017-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Nitric Oxide Other / unclassified 80 ppm Inhaled